The University of Chicago Header Logo

Connection

Shabaana Khader to Mycobacterium tuberculosis

Back to Details
This is a "connection" page, showing publications Shabaana Khader has written about Mycobacterium tuberculosis.
Shabaana Khader
Connection Strength
22.941
Mycobacterium tuberculosis
  1. Nuclear Factor ?B Signaling Deficiency in CD11c-Expressing Phagocytes Mediates Early Inflammatory Responses and Enhances Mycobacterium tuberculosis Control. J Infect Dis. 2024 Aug 16; 230(2):336-345.
    View in: PubMed
    Score: 0.810
  2. A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y. PLoS Pathog. 2024 Apr; 20(4):e1012137.
    View in: PubMed
    Score: 0.790
  3. Phospholipase C epsilon-1 (PLC?1) mediates macrophage activation and protection against tuberculosis. Infect Immun. 2024 Apr 09; 92(4):e0049523.
    View in: PubMed
    Score: 0.785
  4. Lung type 3 innate lymphoid cells respond early following Mycobacterium tuberculosis infection. mBio. 2024 Apr 10; 15(4):e0329923.
    View in: PubMed
    Score: 0.784
  5. Saponin TQL1055 adjuvant-containing vaccine confers protection upon Mycobacterium tuberculosis challenge in mice. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2302070.
    View in: PubMed
    Score: 0.776
  6. Mycobacterium tuberculosis infection drives differential responses in the bone marrow hematopoietic stem and progenitor cells. Infect Immun. 2023 10 17; 91(10):e0020123.
    View in: PubMed
    Score: 0.761
  7. Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons. mBio. 2023 Oct 31; 14(5):e0094623.
    View in: PubMed
    Score: 0.759
  8. A protocol to analyze single-cell RNA-seq data from Mycobacterium tuberculosis-infected mice lung. STAR Protoc. 2023 Sep 15; 4(3):102544.
    View in: PubMed
    Score: 0.757
  9. Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye. Trends Immunol. 2023 09; 44(9):712-723.
    View in: PubMed
    Score: 0.753
  10. Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production. J Clin Invest. 2023 06 15; 133(12).
    View in: PubMed
    Score: 0.746
  11. Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control. Nat Immunol. 2023 05; 24(5):855-868.
    View in: PubMed
    Score: 0.736
  12. CWHM-12, an Antagonist of Integrin-Mediated Transforming Growth Factor-Beta Activation Confers Protection During Early Mycobacterium tuberculosis Infection in Mice. J Interferon Cytokine Res. 2022 08; 42(8):421-429.
    View in: PubMed
    Score: 0.703
  13. Rifampin resistance mutations in the rpoB gene of Enterococcus faecalis impact host macrophage cytokine production. Cytokine. 2022 03; 151:155788.
    View in: PubMed
    Score: 0.676
  14. Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4+ T Cell Activation and Mycobacterium tuberculosis Control. mBio. 2021 08 31; 12(4):e0146821.
    View in: PubMed
    Score: 0.653
  15. Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis. J Immunol Res. 2021; 2021:5517856.
    View in: PubMed
    Score: 0.644
  16. CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome. Front Immunol. 2021; 12:633297.
    View in: PubMed
    Score: 0.637
  17. Immunometabolism during Mycobacterium tuberculosis Infection. Trends Microbiol. 2020 10; 28(10):832-850.
    View in: PubMed
    Score: 0.602
  18. Targeting innate immunity for tuberculosis vaccination. J Clin Invest. 2019 09 03; 129(9):3482-3491.
    View in: PubMed
    Score: 0.574
  19. Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes. Nat Microbiol. 2018 10; 3(10):1099-1108.
    View in: PubMed
    Score: 0.537
  20. A novel role for C-C motif chemokine receptor 2 during infection with hypervirulent Mycobacterium tuberculosis. Mucosal Immunol. 2018 11; 11(6):1727-1742.
    View in: PubMed
    Score: 0.534
  21. A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice. Vaccine. 2017 09 05; 35(37):4983-4989.
    View in: PubMed
    Score: 0.497
  22. Rationalized design of a mucosal vaccine protects against Mycobacterium tuberculosis challenge in mice. J Leukoc Biol. 2017 06; 101(6):1373-1381.
    View in: PubMed
    Score: 0.483
  23. Cytokines and Chemokines in Mycobacterium tuberculosis Infection. Microbiol Spectr. 2016 10; 4(5).
    View in: PubMed
    Score: 0.469
  24. A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis. Hum Vaccin Immunother. 2016 10 02; 12(10):2649-2653.
    View in: PubMed
    Score: 0.460
  25. Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge. Mucosal Immunol. 2015 Sep; 8(5):1099-109.
    View in: PubMed
    Score: 0.418
  26. Chemokines in tuberculosis: the good, the bad and the ugly. Semin Immunol. 2014 Dec; 26(6):552-8.
    View in: PubMed
    Score: 0.410
  27. Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. PLoS Pathog. 2014 May; 10(5):e1004099.
    View in: PubMed
    Score: 0.398
  28. Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol. 2013 Sep; 6(5):972-84.
    View in: PubMed
    Score: 0.362
  29. Lipocalin 2 regulates inflammation during pulmonary mycobacterial infections. PLoS One. 2012; 7(11):e50052.
    View in: PubMed
    Score: 0.359
  30. IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J Immunol. 2011 Nov 15; 187(10):5402-7.
    View in: PubMed
    Score: 0.332
  31. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev. 2008 Dec; 226:191-204.
    View in: PubMed
    Score: 0.273
  32. Interleukin-12 and tuberculosis: an old story revisited. Curr Opin Immunol. 2007 Aug; 19(4):441-7.
    View in: PubMed
    Score: 0.249
  33. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol. 2007 Apr; 8(4):369-77.
    View in: PubMed
    Score: 0.242
  34. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med. 2006 Jul 10; 203(7):1805-15.
    View in: PubMed
    Score: 0.231
  35. Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity. Am J Respir Crit Care Med. 2022 07 01; 206(1):94-104.
    View in: PubMed
    Score: 0.175
  36. Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes. Cell Rep. 2022 06 21; 39(12):110983.
    View in: PubMed
    Score: 0.174
  37. Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model. J Clin Invest. 2022 02 01; 132(3).
    View in: PubMed
    Score: 0.170
  38. CXCL17 Is Dispensable during Hypervirulent Mycobacterium tuberculosis HN878 Infection in Mice. Immunohorizons. 2021 09 24; 5(9):752-759.
    View in: PubMed
    Score: 0.166
  39. The immune landscape in tuberculosis reveals populations linked to disease and latency. Cell Host Microbe. 2021 02 10; 29(2):165-178.e8.
    View in: PubMed
    Score: 0.157
  40. Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB. Front Immunol. 2020; 11:1452.
    View in: PubMed
    Score: 0.153
  41. S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis. J Clin Invest. 2020 06 01; 130(6):3098-3112.
    View in: PubMed
    Score: 0.151
  42. Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus. J Clin Invest. 2020 06 01; 130(6):2789-2799.
    View in: PubMed
    Score: 0.151
  43. Mycobacterium tuberculosis HN878 Infection Induces Human-Like B-Cell Follicles in Mice. J Infect Dis. 2020 04 27; 221(10):1636-1646.
    View in: PubMed
    Score: 0.150
  44. Chronic Immune Activation in TB/HIV Co-infection. Trends Microbiol. 2020 08; 28(8):619-632.
    View in: PubMed
    Score: 0.150
  45. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019 06; 570(7762):528-532.
    View in: PubMed
    Score: 0.141
  46. The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease. Pathog Dis. 2019 06 01; 77(4).
    View in: PubMed
    Score: 0.141
  47. Mucosal-activated invariant T cells do not exhibit significant lung recruitment and proliferation profiles in macaques in response to infection with Mycobacterium tuberculosis CDC1551. Tuberculosis (Edinb). 2019 05; 116S:S11-S18.
    View in: PubMed
    Score: 0.140
  48. In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2018 01 02; 115(1):E62-E71.
    View in: PubMed
    Score: 0.128
  49. Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection. Mucosal Immunol. 2017 07; 10(4):1069-1081.
    View in: PubMed
    Score: 0.121
  50. Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Nat Commun. 2016 12 22; 7:13894.
    View in: PubMed
    Score: 0.119
  51. CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection. Proc Natl Acad Sci U S A. 2016 09 20; 113(38):E5636-44.
    View in: PubMed
    Score: 0.117
  52. Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis. J Clin Invest. 2015 Dec; 125(12):4699-713.
    View in: PubMed
    Score: 0.110
  53. Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis. Nat Commun. 2015 Oct 13; 6:8533.
    View in: PubMed
    Score: 0.110
  54. The DosR Regulon Modulates Adaptive Immunity and Is Essential for Mycobacterium tuberculosis Persistence. Am J Respir Crit Care Med. 2015 May 15; 191(10):1185-96.
    View in: PubMed
    Score: 0.107
  55. Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1. J Immunol. 2014 May 01; 192(9):4263-72.
    View in: PubMed
    Score: 0.098
  56. Chemokines shape the immune responses to tuberculosis. Cytokine Growth Factor Rev. 2013 Apr; 24(2):105-13.
    View in: PubMed
    Score: 0.090
  57. Profiling early lung immune responses in the mouse model of tuberculosis. PLoS One. 2011 Jan 13; 6(1):e16161.
    View in: PubMed
    Score: 0.079
  58. IL-17 in protective immunity to intracellular pathogens. Virulence. 2010 Sep-Oct; 1(5):423-7.
    View in: PubMed
    Score: 0.077
  59. Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration. J Exp Med. 2010 Mar 15; 207(3):591-605.
    View in: PubMed
    Score: 0.074
  60. In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J Immunol. 2009 Dec 15; 183(12):8004-14.
    View in: PubMed
    Score: 0.073
  61. IL-23 and IL-17 in tuberculosis. Cytokine. 2008 Feb; 41(2):79-83.
    View in: PubMed
    Score: 0.064
  62. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol. 2005 Jul 15; 175(2):788-95.
    View in: PubMed
    Score: 0.054
  63. IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J Immunol. 2004 Dec 15; 173(12):7490-6.
    View in: PubMed
    Score: 0.052
  64. The immunoregulatory landscape of human tuberculosis granulomas. Nat Immunol. 2022 02; 23(2):318-329.
    View in: PubMed
    Score: 0.042
  65. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas. mBio. 2021 12 21; 12(6):e0318921.
    View in: PubMed
    Score: 0.042
  66. Formation of Lung Inducible Bronchus Associated Lymphoid Tissue Is Regulated by Mycobacterium tuberculosis Expressed Determinants. Front Immunol. 2020; 11:1325.
    View in: PubMed
    Score: 0.038
  67. Mechanisms of reactivation of latent tuberculosis infection due to SIV coinfection. J Clin Invest. 2019 12 02; 129(12):5254-5260.
    View in: PubMed
    Score: 0.037
  68. HIV-1 and SIV Infection Are Associated with Early Loss of Lung Interstitial CD4+ T Cells and Dissemination of Pulmonary Tuberculosis. Cell Rep. 2019 02 05; 26(6):1409-1418.e5.
    View in: PubMed
    Score: 0.034
  69. Nonpathologic Infection of Macaques by an Attenuated Mycobacterial Vaccine Is Not Reactivated in the Setting of HIV Co-Infection. Am J Pathol. 2017 Dec; 187(12):2811-2820.
    View in: PubMed
    Score: 0.031
  70. LAG3 expression in active Mycobacterium tuberculosis infections. Am J Pathol. 2015 Mar; 185(3):820-33.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.